Alzheimer’s disease affects over 55 million people worldwide and has long been linked to toxic protein buildup and chronic inflammation in the brain.

Translational results bolster confidence as Phase III trial for IMNN-001 in advance epithelial ovarian cancer gets underway.

Explore how adaptive immunity influences Alzheimer’s disease, its impact on disease progression, and potential therapeutic ...

In a new publication, bioengineered multimodal nanofilaments uncloak cancer cells and recruit both innate and adaptive immune systems to eradicate tumorsSHERBROOKE, Québec--(BUSINESS ...

CERo Therapeutics Holdings ( ($CERO) ) has shared an update. On September 22, 2025, CERo Therapeutics Holdings updated its corporate presentation, ...

Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional results from second ...

The NF-κB inhibitors market is poised for growth driven by the increasing prevalence of cancer, autoimmune, and inflammatory ...

Understanding the intricate workings of a chicken's gastrointestinal tract is crucial for optimising their health and ...

The NF-kB inhibitors market is poised for growth driven by the increasing prevalence of cancer, autoimmune, and inflammatory diseases where NF-kB plays a central role. Additionally, the expected ...

A groundbreaking study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) ...